We are live on ! Find out more
EBA

Eagle Bay Advisors Portfolio holdings

AUM $113M
1-Year Est. Return 22.46%
This Fund
S&P 500
This Quarter Est. Return
+5.59%
1 Year Est. Return
+22.46%
3 Year Est. Return
+62.66%
5 Year Est. Return
+69.45%
10 Year Est. Return
AUM
$261M
AUM Growth
+$96M
Cap. Flow
+$84.2M
Cap. Flow %
32.24%
Top 10 Hldgs %
31.14%
Holding
1,394
New
395
Increased
156
Reduced
386
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 14.44%
2 Consumer Discretionary 6.64%
3 Financials 5.04%
4 Healthcare 4.31%
5 Industrials 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDF icon
951
Cardiff Oncology
CRDF
$65M
$905 ﹤0.01%
339
ABNB icon
952
Airbnb
ABNB
$87.2B
$888 ﹤0.01%
7
BLDP
953
Ballard Power Systems
BLDP
$865M
$857 ﹤0.01%
476
SAFE
954
Safehold
SAFE
$1.19B
$766 ﹤0.01%
29
+15
+107% +$354
INMD icon
955
InMode
INMD
$884M
$746 ﹤0.01%
44
PTON icon
956
Peloton Interactive
PTON
$2.71B
$725 ﹤0.01%
155
YMAB
957
DELISTED
Y-mAbs Therapeutics
YMAB
$658 ﹤0.01%
50
PRDO icon
958
Perdoceo Education
PRDO
$1.99B
$623 ﹤0.01%
28
-35
-56% -$788
CNXC icon
959
Concentrix
CNXC
$1.5B
$615 ﹤0.01%
12
ALLO icon
960
Allogene Therapeutics
ALLO
$604M
$605 ﹤0.01%
216
THFF icon
961
First Financial Corp
THFF
$924M
$570 ﹤0.01%
13
LAB icon
962
Standard BioTools
LAB
$303M
$542 ﹤0.01%
281
DIOD icon
963
Diodes
DIOD
$3.95B
$513 ﹤0.01%
8
OXY.WS icon
964
Occidental Petroleum Corp Warrants
OXY.WS
$31.1B
$476 ﹤0.01%
16
ROG icon
965
Rogers Corp
ROG
$2.31B
$452 ﹤0.01%
4
-12
-75% -$1.34K
DNA icon
966
Ginkgo Bioworks
DNA
$487M
$391 ﹤0.01%
48
-1
-2% -$10
PLUG icon
967
Plug Power
PLUG
$2.87B
$391 ﹤0.01%
173
HRTX icon
968
Heron Therapeutics
HRTX
$86.9M
$384 ﹤0.01%
193
BPYPM
969
Brookfield Property Partners 6.25% Class A Cumulative Redeemable Preferred Units Series 1
BPYPM
$309 ﹤0.01%
+18
New +$287
EHTH icon
970
eHealth
EHTH
$43.2M
$298 ﹤0.01%
73
+28
+62% +$121
BAM icon
971
Brookfield Asset Management
BAM
$75.9B
$284 ﹤0.01%
6
DBI icon
972
Designer Brands
DBI
$298M
$280 ﹤0.01%
38
-14
-27% -$98
FATE icon
973
Fate Therapeutics
FATE
$283M
$266 ﹤0.01%
76
QSI icon
974
Quantum-Si Incorporated
QSI
$171M
$244 ﹤0.01%
277
API
975
Agora
API
$337M
$241 ﹤0.01%
100

Similar funds

Eagle Bay Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Eagle Bay Advisors held 1,394 positions worth $261M, up 58% from $165M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eagle Bay Advisors deployed $84.2M of net new capital in Q3 2024, opening 395 new positions and adding to 156 existing holdings. Its largest new stake was JPMorgan Chase & Co 4.20% Series MM Preferred Stock: 9,900 shares worth $209K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $1.33M trimmed.

  • Eagle Bay Advisors's largest Q3 2024 buy was JPMorgan Chase & Co 4.20% Series MM Preferred Stock: 9,900 shares worth $209K.
  • Eagle Bay Advisors added most to Alibaba in Q3 2024, an estimated $231K increase.
  • Eagle Bay Advisors's biggest Q3 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $1.33M.
  • Eagle Bay Advisors fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2024, selling an estimated $138K.
  • Eagle Bay Advisors's ten largest holdings make up 31% of its $261M portfolio in Q3 2024.
  • Eagle Bay Advisors opened 395 new positions and closed 31 in Q3 2024.
  • Eagle Bay Advisors's portfolio value rose 58% quarter-over-quarter to $261M.

Based on Eagle Bay Advisors's 13F filing for Q3 2024, filed 22 Oct 2024.